Skip to content
lifestyle.longislandreport.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Annovis Bio Inc.
Annovis to Host Corporate Update Webinar on September 2, 2026
August 25, 2026
Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results
August 14, 2026
Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease
July 7, 2026
Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer
July 1, 2026
Annovis Bio Regains NYSE Listing Compliance
May 26, 2026
Annovis Publishes Phase 2/3 Alzheimer’s Trial Results in Nature Portfolio
April 29, 2026
Annovis Publishes Phase 2/3 Alzheimer’s Trial Results in Nature Portfolio
April 29, 2026
Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants
April 9, 2026
Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections
April 2, 2026
Annovis Publishes Historical Review of Buntanetap in The Scientist
March 31, 2026
1
2
Next Page
→